InvestorsHub Logo

sludgehound

04/23/14 6:10 PM

#539463 RE: EZ2 #539444

ISRG yeah. Don't like high ticket gaps

That's some rough drop. Fair amt red vol too.

fwiw small guy DEJ $0.275 is uppy hrs on some news. And Zacks tipper their tgt to 0.52 close .275 +.0452 3M lite vol.

Been in hands of oral surgeon so bit blitzed from all that. Took a super long walk in Man'h today which added to to blood flow, lol.
Big hole needing to heal up. Fast and no pain, just no appetite. Uggy. Haven’t had any issues until this one. Take day or so to
get handle on things again.

sludgehound

04/24/14 1:08 PM

#539480 RE: EZ2 #539444

ISRG write up Zacks, down again
looks off a buckish so far

Weakness Seen in Intuitive Surgical (ISRG): Stock Tumbles 11.5%

Zacks
By Zacks Equity Research
6 hours ago

Delcath Systems (DCTH) Worth Watching: Stock Soars 20.1% Zacks
Catamaran Corporation (CTRX) in Focus: Stock Drops 5.9% Zacks
Weakness Seen in NQ Mobile (NQ): Stock Tanks 13.0% Zacks
MacroGenics Slumps: MGNX Falls 7.5% in Session Zacks
Ambit Biosciences Slumps: AMBI Falls 13.0% in Session Zacks

Intuitive Surgical, Inc. (ISRG) saw a big move last session, as the company’s shares fell by about 12% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the most recent downtrend for ISRG, as the stock is now down around 31% since April 3.

This slump shouldn’t be too much of a surprise to investors, as this da Vinci surgical systems manufacturer has seen 5 negative revisions in the past few weeks and its current year earnings consensus has moved lower over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.

ISRG currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Some better-ranked stocks in the Medical Instruments industry include Delcath Systems, Inc. (DCTH), Accuray Incorporated (ARAY) and Globus Medical, Inc. (GMED). Among these stocks, Delcath holds a Zacks Rank #1 (Strong Buy) and Accuray and Globus hold a Zacks Rank #2 (Buy).